Test Price
2,800 AED✅ Home Collection Available
TUBB3 Gene Sequencing for CFEOM3A in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Interpretation by our Consultant Medical Genetics team.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
TUBB3 Gene Sequencing identifies pathogenic variants in the TUBB3 gene associated with congenital fibrosis of extraocular muscles type 3A (CFEOM3A), a rare ophthalmic disorder. This next-generation sequencing (NGS) test provides definitive molecular diagnosis to guide clinical management and genetic counselling.
| Feature | Our Test (NGS) | Closest Alternative (Sanger) |
|---|---|---|
| Methodology | Next-Generation Sequencing (full coding exons ± flanking introns) | Sanger sequencing of selected exons |
| Sensitivity | 99.9%, including deep intronic variants | ~95%, limited to targeted regions |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Cost | 2,800 AED | 2,200–2,500 AED |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) notes:
"Genetic testing for CFEOM3A provides a precise molecular diagnosis that empowers families and clinicians to make informed decisions about management and recurrence risk. While the test is highly sensitive, results must always be interpreted in the context of a complete ophthalmic and neurological evaluation. Our team ensures comprehensive pre- and post-test counselling to guide you through every step."
Medication Advisory
Do not discontinue or modify any prescribed medication, therapy, or dietary regimen without consulting your managing physician. This test does not replace medical advice regarding current treatments.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Patients unable to provide informed consent (guardian required for minors) per Federal Decree-Law No. 4 of 2016 on Medical Liability. Active systemic infection or contraindication to venipuncture also preclude collection.
- ER Red Flags: Sudden severe eye pain, acute vision loss, or ocular trauma require immediate emergency evaluation before proceeding with genetic testing.
Patient FAQ & Clinical Guidance
1. What is the TUBB3 gene test and how is it performed?
A: Our NGS-based TUBB3 gene sequencing detects all clinically relevant variants in the TUBB3 gene causing CFEOM3A. A small whole blood sample is collected via venipuncture. The sample undergoes high-depth next-generation sequencing, followed by rigorous bioinformatic analysis and clinical interpretation to generate a comprehensive report.
2. How long does it take to receive TUBB3 test results?
A: Results are delivered in three to four weeks, after exhaustive bioinformatic analysis and clinical interpretation for accuracy. This timeline includes DNA extraction, library preparation, sequencing, variant calling, and expert review. Urgent requests may be accommodated on a case-by-case basis.
3. Is this test covered by health insurance in the UAE?
A: UAE health insurance plans often cover this when prescribed by a specialist, and we verify coverage instantly. Contact our support team on WhatsApp at +971 54 548 8731 for immediate pre-approval check and direct billing assistance. We work with all major UAE insurers.
UAE Regulatory & Data Privacy Adherence
Full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | TUBB3 Gene Sequencing (CFEOM3A) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) |
| Methodology Used | Next-Generation Sequencing (NGS) – full coding exons ± flanking introns |
| ICD-10-CM Code | H49.81 (Congenital fibrosis of extraocular muscles) |
| LOINC Code | 59110-7 (TUBB3 gene mutations detected in Blood or Tissue by Sequencing) |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians